UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.813

Sortiert nach

Prise en charge hémostatique des hémorragies cérébrales sous anticoagulants oraux

Médecine intensive réanimation, 2019-09, Vol.28 (5), p.363-370

2019

Link zum Volltext

Verfügbarkeit prüfen

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Journal of thrombosis and haemostasis, 2018-02, Vol.16 (2), p.209-219

2018

Link zum Volltext

Verfügbarkeit prüfen

The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital‐associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2018-11, Vol.16 (11), p.2336-2340

2018

Link zum Volltext

Verfügbarkeit prüfen

Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post‐partum period: NATA consensus statement

Transfusion medicine (Oxford, England), 2018-02, Vol.28 (1), p.22-39

2018

Link zum Volltext

Verfügbarkeit prüfen

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013

Archives of cardiovascular diseases, 2013-06, Vol.106 (6), p.382-393

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls

Thrombosis and haemostasis, 2012-02, Vol.107 (2), p.379

2012

Link zum Volltext

Verfügbarkeit prüfen

Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting

Anesthesiology (Philadelphia), 2013-06, Vol.118 (6), p.1466-1474

2013

Link zum Volltext

Verfügbarkeit prüfen

Which test to use to measure the anticoagulant effect of rivaroxaban: the anti‐factor Xa assay

Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.579-580

Samama, M. M.

2013

Link zum Volltext

Verfügbarkeit prüfen

The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban‐treated patients: results of an in vitro study

Journal of thrombosis and haemostasis, 2011-01, Vol.9 (1), p.226-228

2011

Link zum Volltext

Verfügbarkeit prüfen

Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor

Thrombosis and haemostasis, 2010-04, Vol.103 (4), p.815

2010

Link zum Volltext

Verfügbarkeit prüfen

Gestion périopératoire des anticoagulants oraux directs

Archives des maladies du coeur et des vaisseaux. Pratique, 2019-02, Vol.2019 (275), p.2-6

Samama, M.

2019

Link zum Volltext

Verfügbarkeit prüfen

Aspirine et prévention de la maladie thromboembolique veineuse périopératoire : recommandations de l’European Society of Anaesthesiology

Journal de médecine vasculaire, 2019-03, Vol.44 (2), p.100-101

Samama, M.

2019

Link zum Volltext

Verfügbarkeit prüfen

Cas particuliers des chirurgies à haut risque thrombotique : chirurgie orthopédique (fractures du bassin, fractures du plateau tibial), chirurgie bariatrique, chirurgie tumorale abdomino-pelvienne

Journal de médecine vasculaire, 2019-03, Vol.44 (2), p.99-99

Samama, M.

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial

British journal of anaesthesia : BJA, 2011-12, Vol.107 (6), p.899-910

2011

Link zum Volltext

Verfügbarkeit prüfen

Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force

British journal of anaesthesia : BJA, 2006-10, Vol.97 (4), p.580-582

2006

Link zum Volltext

Verfügbarkeit prüfen

Postoperative residual neuromuscular block: a survey of management

British journal of anaesthesia : BJA, 2005-11, Vol.95 (5), p.622-626

2005

Link zum Volltext

Verfügbarkeit prüfen

Pertinence de la prescription des examens biologiques et de la radiographie thoracique en réanimation RFE commune SFAR-SRLF

Médecine intensive réanimation, 2019-03, Vol.28 (2), p.172-189

2019

Link zum Volltext

Verfügbarkeit prüfen

Multimodal assessment of non‐specific hemostatic agents for apixaban reversal

Journal of thrombosis and haemostasis, 2015-03, Vol.13 (3), p.426-436

2015

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo reversal of the anticoagulant effects of edoxaban

Thrombosis research, 2014-10, Vol.134 (4), p.909-913

2014

Link zum Volltext

Verfügbarkeit prüfen

Fibrinogen concentrates for post-partum haemorrhage? Do not miss the most relevant population

British journal of anaesthesia : BJA, 2015-04, Vol.114 (4), p.548-550

2015

Link zum Volltext

Verfügbarkeit prüfen

Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban

Journal of thrombosis and haemostasis, 2012-07, Vol.10 (7), p.1433-1436

2012

Link zum Volltext

Verfügbarkeit prüfen

Influence des nouveaux anticoagulants sur les examens de la coagulation Intérêt en clinique

Archives des maladies du coeur et des vaisseaux. Pratique, 2013-06, Vol.2013 (219), p.21-27

2013

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Venous Thromboembolism

Chest, 2008-06, Vol.133 (6), p.381S-453S

2008

Link zum Volltext

Verfügbarkeit prüfen

An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

Thrombosis and haemostasis, 2010-11, Vol.104 (5), p.1078

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer

Journal of thrombosis and haemostasis, 2006-08, Vol.4 (8), p.1693-1700

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.813

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.198)
Mit Volltextzugriff
(1.202)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(903)
Science & Technology
(575)
Life Sciences & Biomedicine
(557)
Female
(328)
Male
(295)
Hematology
(274)
Biological And Medical Sciences
(260)
Cardiovascular System & Cardiology
(236)
Adult
(230)
Middle Aged
(230)
Medical Sciences
(228)
Peripheral Vascular Disease
(217)
Aged
(174)
Anticoagulants - Therapeutic Use
(106)
Risk Factors
(106)
Animals
(105)
Pharmacology. Drug Treatments
(100)
Sciences Biologiques Et Medicales
(98)
Sciences Medicales
(98)
Anesthesiology
(76)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prise en charge hémostatique des hémorragies cérébrales sous anticoagulants oraux

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital‐associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTH

Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post‐partum period: NATA consensus statement

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls

Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting

Which test to use to measure the anticoagulant effect of rivaroxaban: the anti‐factor Xa assay

The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban‐treated patients: results of an in vitro study

Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor

Gestion périopératoire des anticoagulants oraux directs

Aspirine et prévention de la maladie thromboembolique veineuse périopératoire : recommandations de l’European Society of Anaesthesiology

Cas particuliers des chirurgies à haut risque thrombotique : chirurgie orthopédique (fractures du bassin, fractures du plateau tibial), chirurgie bariatrique, chirurgie tumorale abdomino-pelvienne

Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial

Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force

Postoperative residual neuromuscular block: a survey of management

Pertinence de la prescription des examens biologiques et de la radiographie thoracique en réanimation RFE commune SFAR-SRLF

Multimodal assessment of non‐specific hemostatic agents for apixaban reversal

Ex vivo reversal of the anticoagulant effects of edoxaban

Fibrinogen concentrates for post-partum haemorrhage? Do not miss the most relevant population

Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban

Influence des nouveaux anticoagulants sur les examens de la coagulation Intérêt en clinique

Prevention of Venous Thromboembolism

An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer

Suchergebnisse filtern